A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patientsAlessandra Tedeschi, Davide Rossi, Marina Motta et al.|Haematologica|2015Cited by 25
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costsSpyros Kolovos, Rafael Pinedo‐Villanueva, John Ashcroft et al.|Journal of bone oncology|2019Cited by 20
Elective Vs Non-Elective Hospital Admissions By Patients with Multiple Myeloma in England 2014 - 2018Karthik Ramasamy, Rafael Pinedo‐Villanueva, Spyros Kolovos et al.|Blood|2018Cited by 1
PF599 EFFICACY OF BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH CARFILZOMIB-REFRACTORY MYELOMA IN THE UK NCRI CARDAMON TRIALElizabeth H. Phillips, Kwee Yong, William Wilson et al.|HemaSphere|2019Cited by 0